Alloantigen testing by binding assay

Details Alloantigen testing by binding assay Alloantigen testing by binding assay

1991-12-13

1994-03-08

Saunders, David

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

435 792, 435 793, 436518, G01N 33543

Patent

active

052926419

ABSTRACT:
The presence of alloantigen allelic products or antibodies to alloantigen allelic products is determined by employing a support to which alloantigen allelic products are bound, and combining a specimen which contains either the alloantigen allelic products or antibodies to alloantigen allelic products with a reagent comprising antibodies to the alloantigen allelic product(s) of interest. By combining the specimen, reagent and support, and determining the amount of antibody which binds to the support as compared to a negative control, the presence of the alloantigen antigen or anti-alloantigen is related to a reduced amount of antibody binding to the support. The amount of antibody may be determined by any convenient assay.

REFERENCES:
patent: 3654090 (1972-04-01), Schuurs et al.
patent: 4446239 (1984-05-01), Tsuji et al.
patent: 4607009 (1986-08-01), Steplewski et al.
patent: 5110726 (1992-05-01), Ogden
patent: 5132209 (1992-07-01), Vanderbeeken
Y. Iwaki, et al., (1988) Clinical Transplantation 2:81-84. Successful transplants across T warm-positive crossmatches due to IgM antibodies.
Grosse-Wilde and Doxiadis (1989) J. Immunogenetics 16:149-155. Allotyping forHLA Class I using plasma as antigen source.
F. Stevenson, et al. (1986) J. Imm. Methods 86:187-190. Analysis of soluble HLA Class II antigenic material in patients with immunological disease using monoclonal antibodies.
D. Talbot, et al. (1988) J. Imm. Methods 112:279-283. Rapid detection of lowlevels of donor specific IgG by flow cytometry with single and dual colour fluorescence in renal transplantation.
R. Duquesnoy, et al. (1990) Transplantation 50:427-437. Mutiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private Class I HLA determinants.
S. Martin, et al. (1987) Transplantation 50:427-437. Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome.
R. Tsuji, et al. (1985) Tokai J. Exp. Clin. Med. 10:169-174. Biological significance of Ss (serum soluble) HLA-Class I antigens in bone marrow transplantation.
R. Fauchet, et al. (1989) Transplantation 30:114-129. Occurance and specificity of anti-B lymphocyte antibodies in renal allograft recipients.
H. Davies, et al. (1989) Transplantation 47:524-527. Soluble HLA antigens in the circulation of liver graft recipients.
Doxiadis and Grosse-Wilde (1989) Vox Sang 56:196-199. Typing for HLA Class I gene products using plasma as source.
B. R. Clark et al, in E. T. Maggio (ed), Enzyme Immunoassay, CRC Press, Boca Raton, FL, 1980, pp. 167-170.
Immucor Advertisement of Oct. 20, 1986.

Affiliated with

Also associated with

Rating

Alloantigen testing by binding assay does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alloantigen testing by binding assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alloantigen testing by binding assay will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-152506